The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found to be effective in reducing symptoms of these conditions.
The primary factor supporting the market growth includes the growing demand and advancements in telehealth. Post-COVID-19 pandemic, the number of people receiving ketamine via telemedicine has been soared owing to the lockdown restrictions imposed globally by the federal government of all the nations. One rule change allowed providers to prescribe controlled substances including ketamine without first seeing the patient in person.
The adoption of telemedicine and virtual care solutions is a significant driving factor in the globally ketamine treatment market. It increases access to treatment, especially in areas where in-person options are minimal. For instance, in September 2022, Braxia Scientific Corp. launched KetaMD in Florida. KetaMD accepted new patients and finished their first ketamine treatments. Eligible patients, as determined by one of KetaMD’s certified Florida healthcare practitioners, received medically supervised therapies while at home, virtually directed by registered nurses with mental health competence.
Furthermore, Ketamine has been studied for its potential in treating depression and other mood disorders which have not responded to other forms of treatment. It has been seen to offer a possible solution to those struggling with treatment-resistant conditions. in October 2023,Victoria’s first public ketamine clinic has opened It is employing the anesthetic, that is often used as a recreational substance, to assist patients suffering from difficult-to-treat depression.
To Request a Sample of our Report on Ketamine Treatment Market: https://www.omrglobal.com/request-sample/ketamine-treatment-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Route of Administration
- By Application
- By End User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- includes Core One Labs Inc., Enso Discoveries, LLC., Johnson & Johnson Pvt. Ltd., Ketamine Research Institute, Ketamine Wellness Centers, and others.
Ketamine Treatment Market Report Segment
By Route of Administration
- Oral
- Infusions
- Nasal Spray
By Application
- Treatment-Resistant Depression (TRD)
- Anxiety Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Others (Anesthesia and Sedation, Bipolar Depression, and Chronic Pain Management)
By End-User
- Hospitals and Medical Centers
- Specialized Ketamine Clinics
- Psychiatric Hospitals
- Others (Rehabilitation Centers, Primary Care Physicians, Individual Patients and Research and Academic Institutions)
A full Report of Ketamine Treatment Market is Available @ https://www.omrglobal.com/industry-reports/ketamine-treatment-market
Ketamine Treatment Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- Core One Labs Inc.
- Enso Discoveries, LLC.
- Johnson & Johnson Pvt. Ltd.
- Ketamine Research Institute
- Ketamine Wellness Centers
- Klarisana
- Koch Industries, Inc.
- Mindbloom, Inc.
- Pfizer
- co.uk
- Stella MSO LLC
- Unión Químico Farmacéutica, S.A.U.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ketamine-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
